Residual Solvents Analysis in Pharmaceuticals by HS-GC-FID with Newly Added Compounds –USP <467> Procedure A

Applications | 2022 | ShimadzuInstrumentation
GC, HeadSpace
Industries
Pharma & Biopharma
Manufacturer
Shimadzu

Significance of the Topic


Residual solvent analysis is essential for ensuring pharmaceutical safety and regulatory compliance. Quantifying trace-level solvents protects patient health and aligns with international standards such as USP <467>.

Study Objectives and Overview


This work aims to validate a headspace gas chromatography–flame ionization detection (HS-GC-FID) method using nitrogen as carrier gas, following USP <467> Procedure A. It also incorporates three newly classified Class 2 solvents: cyclopentyl methyl ether, tertiary butyl alcohol, and methyl isobutyl ketone.

Methodology and Instrumentation


A Shimadzu HS-20 NX autosampler coupled with a Nexis GC-2030 system was used. Key parameters included:
  • Column: SH-I-624Sil MS (30 m × 0.32 mm ID, 1.80 µm df)
  • Carrier gas: Nitrogen at constant linear velocity (35 cm/s)
  • Headspace conditions: split mode 5:1, pressurizing gas 75 kPa, equilibration 60 min at 80 °C
  • Oven program: hold 40 °C (20 min), ramp 10 °C/min to 240 °C (20 min)
  • Detector: FID at 250 °C with H2 32 mL/min, air 200 mL/min, makeup gas 24 mL/min

Results and Discussion


Class 1 solvents achieved signal-to-noise ratios well above the USP <467> requirement of 5, with carbon tetrachloride showing S/N=8 and RSD for peak areas between 3.6% and 5.3%. Class 2A standards, including the three new solvents, exhibited complete baseline separation (resolution Rs=2.2 for acetonitrile/methylene chloride) and RSD values from 0.6% to 6.7%. Class 2B solvents also met repeatability criteria with RSDs between 1.0% and 6.7%.

Benefits and Practical Applications


Switching to nitrogen carrier gas significantly reduces operating costs without compromising sensitivity or resolution. The validated HS-GC-FID method offers robust quantitation of residual solvents, streamlining quality control processes and supporting regulatory submissions.

Future Trends and Opportunities


Future developments may include alternative low-cost carrier gases, high-efficiency stationary phases for faster separations, and coupling with mass spectrometry for expanded compound coverage. Enhanced automation and data-mining algorithms could further boost throughput and analytical insight.

Conclusion


The optimized HS-GC-FID procedure using nitrogen carrier gas meets all USP <467> criteria for Class 1 and Class 2 residual solvents, including newly added compounds. This approach balances sensitivity, resolution, and cost-effectiveness, reinforcing its value for routine pharmaceutical quality control.

References


  • United States Pharmacopeia, USP <467> Residual Solvents.
  • International Council for Harmonisation, ICH Q3C(R8) Guideline for Residual Solvents, 2021.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Residual Solvents Analysis Based on the 2025 USP <467> and Chinese Pharmacopoeia (ChP 0861)
Residual Solvent Analysis in Pharmaceuticals with N2 Carrier Gas Using Nexis GC-2060 and HS-20 NX
Analysis of USP <467> Residual Solvents Using the Agilent 8697XL Headspace Sampler and Agilent 8890 GC
Residual Solvent Analysis in Pharmaceuticals with N2 Carrier Gas Using Nexis GC-2060 and HS-20 NX